Bristol Myers Squibb Co. (BMY) was held by 38 hedge funds as of June 30, 2026, according to the latest 13F filings. This marks a significant reduction in aggregate holdings, with funds decreasing their share count from approximately 129.9 million to 50.7 million, representing a decline of about 60.93% in this reporting period.
Notably, seven funds increased their positions, while 17 reduced their holdings, and three new positions emerged. The largest decrease came from Panagora Asset Management, which sold 1.4 million shares, contributing to the overall reduction of 1.4 million shares across the holdings of these funds.
Tracking the trends in hedge funds’ 13F filings can uncover broader market insights, as many funds exhibit similar behavior regarding BMY in this latest period.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
